Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of the microbiota composition of colorectal mucosa tissues and adjacent healthy tissues of 40 patients affected by colorectal cancer.

ABSTRACT: Colorectal cancer is a chronic inflammation-associated tumor and the immune system, besides protecting the host from developing tumors, can support the CRC progression. In this scenario, due to its capability to elicit the production of cytokines, gut microbiota is essential to modulate immune response, influencing immunostimulatory or immunosuppressive reactions. So, the investigation of the microbiota-immunity axis in healthy and tumor mucosa is crucial to well understand the cancer development with positive relapses in prevention and treatment.

ORGANISM(S): Homo sapiens

PROVIDER: GSE163366 | GEO | 2020/12/17

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Analysis of the microbiota composition of colorectal mucosa tissues and adjacent healthy tissues of 40 patients affected by colorectal cancer.

Project description:Analysis of the microbiota composition of colorectal mucosa tissues and adjacent healthy tissues of 40 patients affected by colorectal cancer.

| PRJNA685827 | ENA

DNA hypermethylation in colorectal cancer: Colorectal cancer tissues vs. Adjacent non-tumor tissues

Project description:To identify novel hypermethylated genes in colorectal cancer (CRC) and to test their potential application in CRC early diagnosis, we performed a genome-wide screening of 57,723 CpG dinucleotides covering 4,010 genes in paired DNA samples extracted from 3 fresh frozen CRC tissues and their matching non-tumor adjacent tissues from a cohort of 3 CRC patients undergoing curative surgery using MIRA-based microarray. We also validated candidate hypermethylated genes screened by MIRA-based microarray in independent CRC samples using combined bisulfite restriction analysis. A total of 297 CpG dinucleotides in CRC covering 211 genes were found to be hypermethylated in CRC tissues. From these 211 candidate methylated genes, seven novel methylated genes were picked up for validation and three genes were confirmed to be methylated in cancer samples but not in non-cancer samples.We also compared the methylation levels of these three novel hypermethylated genes with those of Vimentin and SEPT9, well-known hypermethylated genes in CRC, and found that methylated PHOX2B, FGF12 and GAD2 were better than methylated Vimentin and SEPT9 in differentiating CRC cancer tissue from normal tissue. Significant enrichment analysis of GO terms of the hypermethylated genes showed that a high proportion of hypermethylated genes in tumor tissues are involved in regulation of transcription.

2011-11-14 | GSE33545 | GEO

DNA hypermethylation in colorectal cancer: Colorectal cancer tissues vs. Adjacent non-tumor tissues

2011-11-14 | E-GEOD-33545 | biostudies-arrayexpress

Gene expression analysis of colorectal tumors and matched adjacent non-tumor colorectal tissues.

2011-06-03 | GSE25070 | GEO

Gene expression analysis of colorectal tumors and matched adjacent non-tumor colorectal tissues.

Project description:We performed gene expression profiling of 26 colorectal tumors and matched histologically normal adjacent colonic tissue samples using the Illumina Ref-8 whole-genome expression BeadChip. We performed an integrated analysis of promoter DNA methylation and gene expression data to investigate the effects of DNA hypermethylation on gene expression. Total RNA was isolated from 26 pairs of fresh frozen colorectal tumor and matched adjacent non-tumor tissue samples. Their gene expression profiles were obtained using the Illumina Ref-8 whole-genome expression BeadChip (HumanRef-8 v3.0, 24,526 transcripts).

2011-06-03 | E-GEOD-25070 | biostudies-arrayexpress

Study on expression of long non-coding RNA in colorectal cancer tissues and adjacent tissues

Project description:Interventions: Case series:No Primary outcome(s): long non-coding Ribonucleic Acid Study Design: Sequential

| 2725570 | ecrin-mdr-crc

FOS Immunohistochemical Staining of Colorectal Cancer and Its Adjacent Tissues

Project description:Colorectal cancer tissue sections were obtained according to the inclusion criteria. The formalin was used to immersed all cancer specimens. And tissues were cut to 5 μm thickness and placed on glass slides before staining. Endogenous peroxidase activity was inhibited and blocked by de-paraffinizing, rehydrating, and using 5% bovine serum albumin at 37ºC for 30 min. The treated sections were incubated with anti-FOS (promab 30360) at 4ºC overnight and washed three times with PBS. After that, it is required that incubation with secondary anti-peroxidation sunflower at 37ºC for 30 minutes. After washing three times again with PBS, the sections were developed in diaminobenzidine and microscopic images were made by light microscopy.

| 6033 | ecrin-mdr-crc

circRNA expression profiles for Human colorectal carcinoma and adjacent normal tissues

Project description:We have employed circRNA microarray expression profiling as a discovery platform to identify the dysregulated circRNAs in CRC.

2019-06-01 | GSE121895 | GEO

Expression data from colorectal cancer and adjacent normal tissues of human

Project description:Dysregulation of RNAs expression is commonly found in cancer and considered to be involved in tumor pathogenesis. We used microarrays to detail the global programme of RNA expression in colorectal cancer.

2023-03-21 | GSE227550 | GEO

Long noncoding RNA (lncRNA) expression profiles in colorectal cancer tissues and paired adjacent normal tissues

Project description:Long noncoding RNAs (lncRNAs) play important roles in the tumorigenesis and metastasis of colorectal cancer (CRC). This study used a lncRNA microarray to analyze the aberrant lncRNA expression profiles in CRC tissues compared with paired adjacent normal tissues as well as CRC with regional lymph nodes metastasis compared with CRC without regional lymph nodes metastasis.

2020-05-12 | GSE84983 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data